CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 11 of 48

Rheumatology (Oxford)

Briefs 401–440 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Predictors of damage accrual by organ domain in systemic lupus erythematosus

    Cohort studyLupus & APS

  2. Rheumatology (Oxford)

    Effects of systemic TNF inhibition on postprandial glucose-regulatory hormones in inflammatory arthritis

    Cohort studyAcross diseases

  3. Rheumatology (Oxford)

    Serum carcinoembryonic antigen levels correlate with disease severity and 1-year survival across different interstitial lung diseases subtypes

    Cohort study

  4. Rheumatology (Oxford)

    The impact of glucocorticoids on the efficacy of JAK inhibitors or non-TNF-targeted biologics in RA

    Cohort studyRA

  5. Rheumatology (Oxford)

    Primary antiphospholipid syndrome and the kidney: biopsy-proven insights from two referral Italian centres

    Case-control studyLupus & APS

  6. Rheumatology (Oxford)

    Elevated levels of serum angiopoietin-1, IL-17, osteopontin and CXCL-9 as markers of vascular inflammation in newly diagnosed PMR

    Diagnostic or prognostic studyVasculitis & PMR

  7. Rheumatology (Oxford)

    Disease progression in patients with systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS)

    Cohort studyLupus & APS

  8. Rheumatology (Oxford)

    Baseline features and functional outcomes in primary central nervous system vasculitis: development and validation of a prognostic model

    Diagnostic or prognostic studyVasculitis & PMR

  9. Rheumatology (Oxford)

    Baseline neutrophil-to-lymphocyte ratio predicts drug retention of IL-6 inhibitors and JAK inhibitors in RA: the ANSWER cohort study

    Cohort studyRA

  10. Rheumatology (Oxford)

    The application of mNGS of bronchoalveolar lavage fluid in dissecting pulmonary infections in patients with CTD-ILD

    Diagnostic or prognostic studyMyositis

  11. Rheumatology (Oxford)

    Tocilizumab vs prednisone in established rheumatoid arthritis patients (TOPIRA): an investigator-initiated randomized clinical trial

    Randomized controlled trialRA

  12. Rheumatology (Oxford)

    Interstitial lung disease in SLE: a 30-year population study

    Cohort studyLupus & APS

  13. Rheumatology (Oxford)

    Prospective study on mental status in RA patients on tumour necrosis factor vs non-tumour necrosis factor-targeted therapies after achieving treatment target

    Cohort studyRA

  14. Rheumatology (Oxford)

    A retrospective observational study of effectiveness of sequential biologic and targeted synthetic DMARDs in psoriatic arthritis in the UK

    Cohort studySpondyloarthritis & PsA

  15. Rheumatology (Oxford)

    Chronic inflammatory burden on aortic valve disorders and atrioventricular block risk in SpA: an ambispective cohort study

    Cohort studySpondyloarthritis & PsA

  16. Rheumatology (Oxford)

    Nailfold videocapillaroscopy abnormalities in autoimmune inflammatory myopathy subsets

    Cross-sectional studyMyositis

  17. Rheumatology (Oxford)

    Infant-onset juvenile idiopathic arthritis: a multicentre retrospective study

    Cohort studyPediatric

  18. Rheumatology (Oxford)

    Phenotypes of patients with more than one autoinflammatory disease-associated gene variant: overlapping and mixed autoinflammatory disorders

    Cohort studyAutoinflammatory & rare

  19. Rheumatology (Oxford)

    Risk of urinary tract infections associated with SGLT2 inhibitor use in patients with RA: a target trial emulation study

    Cohort studyRA

  20. Rheumatology (Oxford)

    Imbalance between serum DNase-I protein levels and enzymatic activity in SLE: link with mitochondrial-DNA and low-density granulocytes

    Cross-sectional studyLupus & APS

  21. Rheumatology (Oxford)

    Comparable 12-month renal response outcomes with medium- vs high-dose starting prednisone in a real-world study of Lupus Nephritis

    Cohort studyLupus & APS

  22. Rheumatology (Oxford)

    Distinct expression profiles of inflammasome-associated genes in systemic juvenile idiopathic arthritis

    Mechanistic studyPediatric

  23. Rheumatology (Oxford)

    Evaluation of a web-based self-monitoring application (MyRA) to empower people with rheumatoid arthritis in daily life

    Cohort studyRA

  24. Rheumatology (Oxford)

    Incidence and risk of nephrolithiasis with uricosuric therapies for the treatment of gout: a systematic review and meta-analysis of randomized controlled trials and cohort studies

    Meta-analysisGout & crystals

  25. Rheumatology (Oxford)

    Sexual function in axial spondyloarthritis: a systematic review and meta-analysis

    Meta-analysisSpondyloarthritis & PsA

  26. Rheumatology (Oxford)

    Clinical and molecular characterization of ILD in patients with overlapping ASyS and SjD: a retrospective observational study

    Cohort studySjögren's & overlap

  27. Rheumatology (Oxford)

    Clinical significance of non-infectious procalcitonin elevation in Still’s disease: a predictor of macrophage activation syndrome

    Cohort studyAutoinflammatory & rare

  28. Rheumatology (Oxford)

    Risk of hospitalization with pneumonia in patients with giant cell arteritis and anti-neutrophil cytoplasmic antibody associated vasculitis

    Cohort studyVasculitis & PMR

  29. Rheumatology (Oxford)

    Assessment of interstitial lung disease in systemic sclerosis using oscillometric methods: a novel approach to respiratory assessment

    Diagnostic or prognostic studySystemic sclerosis

  30. Rheumatology (Oxford)

    Two-decade trajectories of gout: a multicentre cohort study of 10 658 Chinese patients with gout

    Cross-sectional studyGout & crystals

  31. Rheumatology (Oxford)

    Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort study

    Cohort studyRA

  32. Rheumatology (Oxford)

    MTX use in the treatment of RA-associated-interstitial lung disease: a systematic review

    Meta-analysisRA

  33. Rheumatology (Oxford)

    Outpatient hospital attendances in people with rheumatoid arthritis during the COVID-19 pandemic and beyond: a cohort study in three nations of the UK

    Cohort studyRA

  34. Rheumatology (Oxford)

    Vascular uptake on 18F-FDG PET/CT predicts relapse in new-onset PMR

    Cohort studyVasculitis & PMR

  35. Rheumatology (Oxford)

    Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease-modifying antirheumatic drugs: results from the BIOBADASER III registry

    Cohort studyRA

  36. Rheumatology (Oxford)

    Clinical efficacy of JAK inhibitors for RA patients with poor-prognosis factors: the ANSWER cohort study

    Cohort studyRA

  37. Rheumatology (Oxford)

    Fine particulate matter air pollution and anti-nuclear antibodies

    Cross-sectional studyAcross diseases

  38. Rheumatology (Oxford)

    Hormonal risk factors and androgen and glucocorticoid dysregulation in Sjogren’s disease and non-Sjogren’s sicca

    Cross-sectional studySjögren's & overlap

  39. Rheumatology (Oxford)

    Identification of a distinctive gene signature associated with disease activity in granulomatous myositis

    Mechanistic studyMyositis

  40. Rheumatology (Oxford)

    Injury and local injection and the risk of foot/ankle osteoarthritis: a case–control study in retired UK male professional footballers

    Case-control studyOsteoarthritis

All 1,905 Briefs in ExploreShowing Briefs 401–440 of 1,905, newest first